The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID: a Systematic Review and meta-analysis
G Sun, K Lin, J Ai, W Zhang - Clinical Microbiology and Infection, 2024 - Elsevier
Background Whether treatment during acute COVID results in protective efficacy against
long COVID incidence remains unclear. Objectives To assess the relationship between …
long COVID incidence remains unclear. Objectives To assess the relationship between …
[HTML][HTML] Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: a systematic review and network meta-analysis
J Jiang, Y Li, Q Jiang, Y Jiang, H Qin, Y Li - Journal of Infection, 2024 - Elsevier
Objectives This study aimed to determine the association of early use of oral antiviral drugs
(including nirmatrelvir-ritonavir and molnupiravir) with the risk of PCC and compare the …
(including nirmatrelvir-ritonavir and molnupiravir) with the risk of PCC and compare the …
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
H Wang, Y Wei, CT Hung, G Lin, X Jiang… - The Lancet Infectious …, 2024 - thelancet.com
Background Studies have established the short-term efficacy of nirmatrelvir–ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …
[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …
Long-term cardiovascular, cerebrovascular, and thrombotic complications after SARS-CoV-2-Omicron infection: a retrospective cohort study
Objectives Evidence suggests that some COVID-19 survivors experience a wide range of
post-COVID-19 sequelae; however, the majority of studies were conducted prior to …
post-COVID-19 sequelae; however, the majority of studies were conducted prior to …
[HTML][HTML] The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the …
J Gu, Y Wang, J Zhang, C Wang - IJC Heart & Vasculature, 2024 - Elsevier
Background Although prophylactic anticoagulation therapy is suggested to be adopted in
severe COVID-19 patients, its effects on the long-term cardiovascular (CV) outcomes …
severe COVID-19 patients, its effects on the long-term cardiovascular (CV) outcomes …
The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave …
J Gu, ZH Han, C Wang, J Zhang - Cardiovascular Drugs and Therapy, 2024 - Springer
Purpose Even though nirmatrelvir–ritonavir can improve the short-term morbidity and
mortality in COVID-19 patients, the effects of this treatment on long-term major adverse …
mortality in COVID-19 patients, the effects of this treatment on long-term major adverse …